On initiation or discontinuation of guselkumab in patients who will be getting concomitant CYP450 substrates, significantly All those with a slim therapeutic index, consider monitoring for therapeutic effect. Con el fin de protegerlos de una intoxicación, siempre use tapaderas de seguridad